CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10,521 enrolled
Drug / intervention
Alert to providerother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04147832
NCT04147832N/ACompleted

Epividian, Inc. and AIDS Healthcare Foundation: Positive Pathways - HIV Retention in Care RIC-20190212 (Pro00037143)

Epividian·observational·Posted Nov 1, 2019·Updated Feb 25, 2025

In Brief

An observational study evaluating Alert to provider for HIV/AIDS. Completed, enrolled 10,521 participants across 1 site.

Detailed Summary

The primary objective of this study is to evaluate the effectiveness of a clinical decision support system (CDSS) combined with enhanced patient contact to retain HIV+ patients in care with AIDS Healthcare Foundation. Specifically, the study aims to evaluate the effectiveness of having the patient's primary caregiver (or dedicated case manager) telephone the patient when the patient is identified as a significant risk to loss of follow-up (at-risk patients) based upon pre-defined criteria. The secondary objective Gain a better understanding about the implementation of the study's procedures in clinical practice by evaluating survey responses delivered to participating healthcare providers and AHF staff members engaging with the study's intervention.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV/AIDS
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedNov 1, 2019
Enrollment StartOct 5, 2020
Primary CompletionJul 31, 2021
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 6.7 years ago

Interventions

Alert to providerother

Provider will receive an alert of sub-optimal patient attendance using 4 rules.